| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 4, 2007
From the Boston Adult Congenital Heart Service, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, and Children’s Hospital Boston, Harvard Medical School, Boston, Mass. * To whom correspondence should be addressed. E-mail: paul.khairy{at}cardio.CHBoston.org
or michael.landzberg{at}cardio.CHBoston.org.
Background—To better define determinants of mortality in patients with univentricular physiology, a database registry was created of patients born in 1985 or earlier with Fontan surgery who were followed up at Childrens Hospital Boston. Methods and Results—A total of 261 patients, 121 of whom (46.4%) were women, had a first Fontan surgery at a median age of 7.9 years: right atrium–to–pulmonary artery connection in 135 (51.7%); right atrium to right ventricle in 25 (9.6%); and total cavopulmonary connection in 101 (38.7%). Over a median of 12.2 years, 76 (29.1%) died, 5 (1.9%) had cardiac transplantation, 5 (1.9%) had Fontan revision, and 21 (8.0%) had Fontan conversion. Perioperative mortality decreased steadily over time and accounted for 68.4% of all deaths. In early survivors, actuarial freedom from death or transplantation was 93.7%, 89.9%, 87.3%, and 82.6% at 5, 10, 15, and 20 years, respectively, with no significant difference between right atrium to pulmonary artery versus total cavopulmonary connection. Late deaths were classified as sudden in 7 patients (9.2%), thromboembolic in 6 (7.9%), heart failure–related in 5 (6.7%), sepsis in 2 (2.6%), and other in 4 (5.2%). Most sudden deaths were of presumed arrhythmic origin with no identifiable predictor. Independent risk factors for thromboembolic death were lack of antiplatelet or anticoagulant therapy (hazard ratio [HR], 91.6; P=0.0041) and clinically diagnosed intracardiac thrombus (HR, 22.7; P=0.0002). Independent predictors of heart failure death were protein-losing enteropathy (HR, 7.1; P=0.0043), single morphologically right ventricle (HR, 10.5; P=0.0429), and higher right atrial pressure (HR, 1.3 per 1 mm Hg; P=0.0016). Conclusion—In perioperative survivors of Fontan surgery, gradual attrition occurs predominantly from thromboembolic, heart failure–related, and sudden deaths.
Accepted on October 22, 2007
Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan Surgery
Paul Khairy MD, PhD*,
Related Article:
Circulation 2008 117: 1-3.
This article has been cited by other articles:
![]() |
P. Khairy and M. J. Landzberg Adult Congenital Heart Disease: Toward Prospective Risk Assessment of a Multisystemic Condition Circulation, May 6, 2008; 117(18): 2311 - 2312. [Full Text] [PDF] |
||||
![]() |
W. M. Gersony Fontan Operation After 3 Decades: What We Have Learned Circulation, January 1, 2008; 117(1): 13 - 15. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |